- Home
- DJT vs CRNX Comparison
DJT vs CRNX Comparison
Compare DJT & CRNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DJT
- CRNX
- Stock Information
- Founded
- DJT 2021
- CRNX 2008
- Country
- DJT United States
- CRNX United States
- Employees
- DJT N/A
- CRNX N/A
- Industry
- DJT Computer Software: Programming Data Processing
- CRNX Biotechnology: Pharmaceutical Preparations
- Sector
- DJT Technology
- CRNX Health Care
- Exchange
- DJT Nasdaq
- CRNX Nasdaq
- Market Cap
- DJT 4.5B
- CRNX 4.1B
- IPO Year
- DJT N/A
- CRNX 2018
- Fundamental
- Price
- DJT $11.12
- CRNX $46.09
- Analyst Decision
- DJT
- CRNX Buy
- Analyst Count
- DJT 0
- CRNX 11
- Target Price
- DJT N/A
- CRNX $71.00
- AVG Volume (30 Days)
- DJT 6.2M
- CRNX 1.5M
- Earning Date
- DJT 11-07-2025
- CRNX 11-06-2025
- Dividend Yield
- DJT N/A
- CRNX N/A
- EPS Growth
- DJT N/A
- CRNX N/A
- EPS
- DJT N/A
- CRNX N/A
- Revenue
- DJT $3,677,900.00
- CRNX $1,535,000.00
- Revenue This Year
- DJT N/A
- CRNX $405.68
- Revenue Next Year
- DJT N/A
- CRNX $1,034.87
- P/E Ratio
- DJT N/A
- CRNX N/A
- Revenue Growth
- DJT 9.14
- CRNX 47.74
- 52 Week Low
- DJT $10.18
- CRNX $24.10
- 52 Week High
- DJT $43.46
- CRNX $60.34
- Technical
- Relative Strength Index (RSI)
- DJT 29.80
- CRNX 62.80
- Support Level
- DJT $10.18
- CRNX $43.07
- Resistance Level
- DJT $11.06
- CRNX $45.16
- Average True Range (ATR)
- DJT 0.55
- CRNX 2.08
- MACD
- DJT -0.02
- CRNX 0.22
- Stochastic Oscillator
- DJT 27.10
- CRNX 96.18
About DJT Trump Media & Technology Group Corp.
Trump Media & Technology Group Corp is a media and technology company rooted in social media, digital streaming, information technology infrastructure, and more. Its initial product launch will focus on its social media platform, Truth Social, which encourages an open, free, and honest conversation without discriminating against political ideology.
About CRNX Crinetics Pharmaceuticals Inc.
Crinetics Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. Its products include Paltusotine and Atumelnant.